PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells

BACKGROUND: The histone methyltransferase G9a has recently been identified as a potential target for epigenetic therapy of acute myeloid leukemia (AML). However, the effect of G9a inhibition on leukemia stem cells (LSCs), which are responsible for AML drug resistance and recurrence, is unclear. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Ji Eun, Eom, Ju-In, Jeung, Hoi-Kyung, Chung, Haerim, Kim, Yu Ri, Kim, Jin Seok, Cheong, June-Won, Min, Yoo Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158163/
https://www.ncbi.nlm.nih.gov/pubmed/32293500
http://dx.doi.org/10.1186/s13046-020-01565-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158163/
https://www.ncbi.nlm.nih.gov/pubmed/32293500
http://dx.doi.org/10.1186/s13046-020-01565-3

Ejemplares similares